| 1021 ACTIVATION OF THE C-KIT-STEM CELL FACTOR (SCF) SYSTEM IN RENAL TUMORS–CELLULAR SHIFT OF C-KIT AS A CRITERION OF MALIGNANCY M Horstmann, J Hennenlotter, S Huber, LM Geiger, U Kuehs, U Vogel, ... European Urology Supplements 4 (8), 376, 2009 | | 2009 |
| 1031 ACTIVATION OF MTOR IN RENAL CELL CARCINOMA DUE TO INCREASED PHOSPHORYLATION RATHER THAN PROTEIN OVER EXPRESSION S Kruck, J Hennenlotter, AS Merseburger, PA Ohneseit, D Schilling, ... European Urology Supplements 4 (8), 378, 2009 | | 2009 |
| 115 ANATOMICAL DISTRIBUTION OF PROSTATIC PERIPHERAL NERVE TISSUE-A NOTEABLE PORTION LOCATED ON THE DORSAL SURFACE OF THE APEX J Hennenlotter, I Laible, A Merseburger, A Anastasiadis, U Nagele, ... European Urology Supplements 2 (6), 51, 2007 | 7 | 2007 |
| 123 ASSESSMENT OF MOLECULAR DIFFERENCES BETWEEN EARLY AND LATELY DEVELOPED RENAL CELL CARCINOMA F Janke, S Fuessel, J Hofmann, M Meinhardt, A Hartmann, B Gunawan, ... JOURNAL OF UROLOGY 200 (3), e52-e52, 2018 | | 2018 |
| 123 ASSESSMENT OF MOLECULAR DIFFERENCES BETWEEN EARLY AND LATELY DEVELOPED RENAL CELL CARCINOMA F Janke, S Fuessel, J Hofmann, M Meinhardt, A Hartmann, B Gunawan, ... The Journal of Urology 185 (4S), e52-e52, 2011 | | 2011 |
| 131 DISTRIBUTION OF EXCISED PERIPHERAL NERVE TISSUE ON RADICAL PROSTATECTOMY SPECIMEN'S NERVE SPARING ASPECT KD Sievert, J Hennenlotter, I Laible, A Merseburger, A Anastasiadis, ... European Urology Supplements 2 (6), 55, 2007 | 2 | 2007 |
| 132 IS MULTIPHASE COMPUTED TOMOGRAPHY AN APPROPRIATE TOOL TO DIFFERENTIATE BETWEEN RENAL ONCOCYTOMA AND RENAL CELL CARCINOMA? G Gakis, HP Schlemmer, S Kruck, D Schilling, AS Merseburger, A Stenzl, ... European Urology Supplements 4 (8), 153, 2009 | | 2009 |
| 1401 IS THE NODAL YIELD ASSOCIATED WITH OUTCOMES IN BLADDER CANCER PATIENTS WITHOUT NODAL METASTASIS AT RADICAL CYSTECTOMY? M Rink, SF Shariat, D Green, EK Cha, J Hansen, JP Fitzgerald, ... The Journal of Urology 187 (4S), e569-e569, 2012 | | 2012 |
| 1603: PTEN-AKT-P27 KIP1 Expression Profile in Benign, Cancerous, Lymph Node Positive and Hormone Refractory Prostate Cancer Tissue AS Merseburger, J Hennenlotter, M Horstmann, R Knuechel-Clarke, ... The Journal of Urology 173 (4S), 434-434, 2005 | | 2005 |
| 1786P Effect of rapid ultra-low prostate-specific antigen decline (UL PSA) in TITAN patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) who received … AS Merseburger, N Agarwal, A Bjartell, H Uemura, Á Juárez, A Bhaumik, ... Annals of Oncology 34, S965-S966, 2023 | 4 | 2023 |
| 1824 INTERNATIONAL COOPERATION IN ENDOUROLOGY: PERCUTANEOUS AND FLEXIBLE URETEROSCOPIC TREATMENT OF LOWER POLE KIDNEY STONES A Breda, F Sanguedolce, C Scoffone, P Kallidonis, E LIatsikos, ... The Journal of Urology 185 (4S), e731-e732, 2011 | | 2011 |
| 1836P Blood based biomarkers identify metastatic castration-resistant prostate cancer (mCRPC) with the greatest benefit from continuing enzalutamide (ENZ) beyond progression in … MR Vico, D Wetterskog, S Thakali, F Orlando, AK Jayaram, O Vainauskas, ... Annals of Oncology 34, S994, 2023 | | 2023 |
| 186Correlation between the tumour size and the biological aggressiveness of renal cell cancers classified as T1 disease M Kuczyk, G Wegener, A Merseburger, U Jonas, A Stenzl European Urology Supplements 3 (4), 49, 2005 | | 2005 |
| 1955: MRI-Guided Biopsy of the Prostate Continues to be Promising as a Diagnostic Alternative in Patients with Elevated PSA and Prior Negative Trus Biopsies AG Anastasiadis, MP Lichy, U Nagele, AS Merseburger, MA Kuczyk, ... The Journal of Urology 177 (4S), 649-649, 2007 | | 2007 |
| 198 Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma H Tezval, K Gebauer, I Peters, N Dubrowinskaja, J Hennenlotter, M Abbas, ... European Urology Supplements 1 (12), e198, 2013 | | 2013 |
| 199 Prediction of targeted therapy response in metastatic renal cell carcinoma by DNA methylation markers I Peters, N Dubrowinskaja, M Abbas, C Seidel, M Kogosov, R Scherer, ... European Urology Supplements 1 (13), e199, 2014 | | 2014 |
| 209 MRNA EXPRESSION OF FIBRONECTIN 1 CORRELATES WITH RISK OF PROGRESSION IN RENAL CELL CANCER S Waalkes, F Atschekzei, AS Merseburger, MW Kramer, J Hennenlotter, ... The Journal of Urology 183 (4S), e82-e83, 2010 | | 2010 |
| 231: Pten-AKT-P27 KIP1 Expression Profile in Benigne, Adjacent and Prostate Cancer Tissue AS Merseburger, J Hennenlotter, C Mueller, P Simon, M Horstmann, ... The Journal of Urology 173 (4S), 63-64, 2005 | | 2005 |
| 232 INTERNATIONAL COOPERATION IN ENDOUROLOGY: PERCUTANEOUS AND FLEXIBLE URETEROSCOPIC TREATMENT OF LOWER POLE KIDNEY STONES F Millan, F Sanguedolce, A Di Stasio, C Cracco, C Scoffone, E Liatsikos, ... European Urology Supplements 2 (10), 95, 2011 | | 2011 |
| 2407TiP SunRISe-3: TAR-200 plus cetrelimab (CET) or TAR-200 versus intravesical bacillus Calmette-Guerin (BCG) in patients (pts) with BCG-naive high-risk non-muscle-invasive … A Necchi, JWF Catto, TB Powles, F Guerrero-Ramos, G Simone, ... Annals of Oncology 34, S1224, 2023 | 4 | 2023 |
Milan HoraDept. of Urology, University Hospital Plzeň, CZ在 fnplzen.cz 的电子邮件经过验证
